293 related articles for article (PubMed ID: 30890624)
1. Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE).
Chayahara N; Mukohara T; Tachihara M; Fujishima Y; Fukunaga A; Washio K; Yamamoto M; Nakata K; Kobayashi K; Takenaka K; Toyoda M; Kiyota N; Tobimatsu K; Doi H; Mizuta N; Marugami N; Kawaguchi A; Nishigori C; Nishimura Y; Minami H
Oncologist; 2019 Jul; 24(7):885-e413. PubMed ID: 30890624
[TBL] [Abstract][Full Text] [Related]
2. Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.
Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Kerrouche N; Tan J
Am J Clin Dermatol; 2018 Apr; 19(2):275-286. PubMed ID: 29549588
[TBL] [Abstract][Full Text] [Related]
3. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
[TBL] [Abstract][Full Text] [Related]
4. A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel.
Chularojanamontri L; Tuchinda P; Kulthanan K; Varothai S; Winayanuwattikun W
J Dermatolog Treat; 2016; 27(2):140-5. PubMed ID: 26293170
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
Maiti R; Sirka CS; Ashique Rahman MA; Srinivasan A; Parida S; Hota D
Clin Drug Investig; 2017 Nov; 37(11):1083-1091. PubMed ID: 28913735
[TBL] [Abstract][Full Text] [Related]
6. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
Ioannides D; Rigopoulos D; Katsambas A
Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
[TBL] [Abstract][Full Text] [Related]
7. Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parallel-group, Controlled Study of a New Treatment--Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel.
Weiss J; Stein Gold L; Leoni M; Rueda MJ; Liu H; Tanghetti E
J Drugs Dermatol; 2015 Dec; 14(12):1427-35. PubMed ID: 26659936
[TBL] [Abstract][Full Text] [Related]
8. Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.
Scope A; Agero AL; Dusza SW; Myskowski PL; Lieb JA; Saltz L; Kemeny NE; Halpern AC
J Clin Oncol; 2007 Dec; 25(34):5390-6. PubMed ID: 18048820
[TBL] [Abstract][Full Text] [Related]
9. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
Thiboutot D; Arsonnaud S; Soto P
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.
Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart T; Swinyer L; Whitmore C; Baker M; Czernielewski J
J Am Acad Dermatol; 1996 Mar; 34(3):482-5. PubMed ID: 8609263
[TBL] [Abstract][Full Text] [Related]
12. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
[TBL] [Abstract][Full Text] [Related]
13. A Double-Blinded, Randomized, Vehicle-Controlled Study of the Efficacy of Moisturizer Containing Licochalcone A, Decanediol, L-Carnitine, and Salicylic Acid for Prevention of Acne Relapse in Asian Population.
Kulthanan K; Trakanwittayarak S; Tuchinda P; Chularojanamontri L; Limphoka P; Varothai S
Biomed Res Int; 2020; 2020():2857812. PubMed ID: 33150170
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide/0.1% adapalene in the acne treatment: a randomized, split-face, open-label, single-center study.
Zheng Y; Yin S; Xia Y; Chen J; Ye C; Zeng Q; Lai W
Cutan Ocul Toxicol; 2019 Mar; 38(1):48-54. PubMed ID: 30173582
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of calcipotriol as a potential topical treatment of acne vulgaris: a randomized, controlled, triple blinded, split-face clinical trial.
Mahran A; Ghazally A; Ali AS; Bakr RM
Clin Exp Dermatol; 2024 Mar; 49(4):348-355. PubMed ID: 37925677
[TBL] [Abstract][Full Text] [Related]
16. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.
Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M
J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384
[TBL] [Abstract][Full Text] [Related]
17. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152
[TBL] [Abstract][Full Text] [Related]
18. Skin toxicities associated with epidermal growth factor receptor inhibitors.
Li T; Perez-Soler R
Target Oncol; 2009 Apr; 4(2):107-19. PubMed ID: 19452131
[TBL] [Abstract][Full Text] [Related]
19. Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.
Eichenfield LF; Jarratt M; Schlessinger J; Kempers S; Manna V; Hwa J; Liu Y; Graeber M;
J Drugs Dermatol; 2010 Jun; 9(6):639-46. PubMed ID: 20645525
[TBL] [Abstract][Full Text] [Related]
20. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Gonzalez P; Vila R; Cirigliano M
J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
